These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2863437)

  • 1. [Effectiveness of a new beta adrenergic blocking agent (penbutolol) in the treatment of ischemic cardiopathy].
    Ortuño Aznar F; Martín Jadraque L
    Med Clin (Barc); 1985 May; 84(19):766-8. PubMed ID: 2863437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of coronary disease with the beta-blocker betapressin].
    Christandl B
    Fortschr Med; 1981 Sep; 99(36):1473-6. PubMed ID: 6117510
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
    Agarwal AK; Ahuja RC; Chandra M; Gupta NN; Hasan M
    J Int Med Res; 1976; 4(6):410-7. PubMed ID: 17557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris.
    Hillis WS; Tweddel AC; Murray RG; Lawrie TD
    Arzneimittelforschung; 1980; 30(9):1595-9. PubMed ID: 7006619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
    Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
    Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term treatment of stable angina pectoris with penbutolol].
    Martín Jadraque L; Ortuño Aznar F
    Med Clin (Barc); 1986 Apr; 86(13):540-2. PubMed ID: 3713329
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of SD/1601 on tolerance to exercise in patients with angina.
    Maggi A; Mariani G; Tettamanti R; Tallone G
    G Ital Cardiol; 1975; 5(1):142-8. PubMed ID: 235477
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris].
    Lai C; Tallu B; Onnis E; Pirisi R; Cioglia G; Cherchi A
    Cardiologia; 1984 Dec; 29(12):605-14. PubMed ID: 6152549
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind comparison of prenylamine and penbutolol in patients with angina pectoris.
    Slegers LC; Vermeulen A; Sumajow CA
    J Int Med Res; 1985; 13(4):229-35. PubMed ID: 3899772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
    Balestrini AE; Menzio AC; Cabral R; Feldman R; Mercogliano C; Flichtentrei D; Albera HP; Vazquez A
    Eur J Clin Pharmacol; 1984; 27(1):1-5. PubMed ID: 6386486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose finding in angina--results with epanolol.
    Omland TM; von Brandis C; Abrahamsen AM
    Drugs; 1989; 38 Suppl 2():35-8. PubMed ID: 2575978
    [No Abstract]   [Full Text] [Related]  

  • 13. A double blind placebo controlled study of celiprolol in the treatment of angina pectoris.
    Harston WE; Eff J; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():55-8. PubMed ID: 2864066
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.
    Nordenfelt I; Olsson L; Persson S
    Eur J Clin Pharmacol; 1974; 7(3):157-62. PubMed ID: 4152812
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of once daily penbutolol in chronic stable angina. An objective comparison with long-acting propranolol.
    Bowles MJ; Khurmi NS; Bala Subramanian V; Raftery EB
    Int J Cardiol; 1984 Feb; 5(2):131-42. PubMed ID: 6365803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of a prolonged-action beta-blocker (nadolol) in the therapy of stable angina. Ergometric study].
    Galati A; Coletta C; Carunchio A; Bordi L; Salustri A; Tornese C; Cigna G
    Minerva Cardioangiol; 1985 Dec; 33(12):845-50. PubMed ID: 2869449
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventricular arrhythmias during exercise testing and daily activities in patients with stable angina pectoris before and during Aldisem and penbutolol treatment.
    Catipović-Veselica K; Skrinjarić-Cincar S; Catipović B
    Acta Med Croatica; 1993; 47(3):129-33. PubMed ID: 7509665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation, by the bicycle ergometry test ECG, of the efficacy of a single dosage of nadolol, in patients with stable angina pectoris].
    Capuano V; De Vita S; Riccio MD; De Martino M; Mondillo G
    Minerva Cardioangiol; 1985 Nov; 33(11):739-44. PubMed ID: 2868431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.